O'Keefe Stevens Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.34M Buy
15,567
+1,843
+13% +$162K 0.27% 42
2026
Q2
$1.07M Buy
13,724
+512
+4% +$41.3K 0.22% 43
2026
Q1
$1.14M Buy
13,212
+1,125
+9% +$108K 0.28% 41
2025
Q4
$1.16M Buy
12,087
+721
+6% +$70K 0.3% 35
2025
Q3
$1.08M Buy
11,366
+248
+2% +$22.8K 0.29% 37
2025
Q2
$969K Buy
11,118
+1,651
+17% +$140K 0.27% 39
2025
Q1
$851K Buy
9,467
+2,007
+27% +$180K 0.28% 39
2024
Q4
$596K Buy
7,460
+2,031
+37% +$176K 0.18% 43
2024
Q3
$489K Buy
5,429
+1,628
+43% +$137K 0.15% 47
2024
Q2
$299K Buy
3,801
+1,264
+50% +$104K 0.1% 52
2024
Q1
$221K Buy
+2,537
New +$217K 0.07% 59

Other funds holding MDT

O'Keefe Stevens Advisory's MDT Position: Q3 2026 in Review

O'Keefe Stevens Advisory increased its Medtronic (MDT) stake by 13% in Q3 2026, buying an estimated $162K and bringing the position to 15,567 shares worth $1.34M. The position accounts for 0.27% of the portfolio, ranked #42.

O'Keefe Stevens Advisory first reported a position in MDT in Q1 2024 and has held it in 11 quarters since. 1,325 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • O'Keefe Stevens Advisory held 15,567 shares of Medtronic worth $1.34M as of Q3 2026.
  • O'Keefe Stevens Advisory bought 1,843 Medtronic shares in Q3 2026, an estimated $162K.
  • Medtronic made up 0.27% of O'Keefe Stevens Advisory's portfolio in Q3 2026, its #42 holding.
  • O'Keefe Stevens Advisory first reported a position in Medtronic in Q1 2024 and has held it in 11 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q3 2026, filed 9 Oct 2026.